Zobrazeno 1 - 10
of 1 457
pro vyhledávání: '"A. Poell"'
Autor:
Tara Muijlwijk, Irene H. Nauta, Anabel van der Lee, Kari J. T. Grünewald, Arjen Brink, Sonja H. Ganzevles, Robert J. Baatenburg de Jong, Lilit Atanesyan, Suvi Savola, Mark A. van de Wiel, Laura A. N. Peferoen, Elisabeth Bloemena, Rieneke van de Ven, C. René Leemans, Jos B. Poell, Ruud H. Brakenhoff
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Cancer is caused by an accumulation of somatic mutations and copy number alterations (CNAs). Besides mutations, these copy number changes are key characteristics of cancer development. Nonetheless, some tumors show hardly any CNAs, a remarka
Externí odkaz:
https://doaj.org/article/225436245a4a4f2badda609a77918405
Autor:
H. D. Biesma, T. T. D. Soeratram, H. F. van Essen, J. M. P. Egthuijsen, J. B. Poell, E. van Dijk, E. Meershoek - Klein Kranenbarg, H. H. Hartgrink, C. J. H. van de Velde, M. A. van de Wiel, B. Ylstra, N. C. T. van Grieken
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-8 (2024)
Abstract Background The Cancer Genome Atlas (TCGA) recognizes four molecular subgroups of gastric cancer: Epstein-Barr virus (EBV) positive, microsatellite instable (MSI), genomically stable (GS), and chromosomal instable (CIN). Since a GS/CIN classi
Externí odkaz:
https://doaj.org/article/b60dce1353ca44c89ccfe80e176badf9
Autor:
Poell, Rob F., author
Publikováno v:
Making Sense of the Learning Turn : Why and In What Sense Toys, Organizations, Economies, and Cities are "Learning", 2024.
Externí odkaz:
https://doi.org/10.1093/oso/9780192865977.003.0008
Publikováno v:
International Journal of Educational Management, 2023, Vol. 38, Issue 1, pp. 96-114.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJEM-04-2023-0169
Autor:
Bernard A Fox, Rieneke van de Ven, Carmen Ballesteros-Merino, Tara Muijlwijk, Sonja H Ganzevles, Ruud H Brakenhoff, Jos B Poell, Dennis N L M Nijenhuis, C René Leemans, Laura A N Peferoen, Elisabeth Bloemena, Fatima Ekhlas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Approximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond.
Externí odkaz:
https://doaj.org/article/706241e19a784c6ebfc691493690aafb
Publikováno v:
Internet Policy Review, Vol Volume 13, Iss Issue 2 (2024)
Against the backdrop of ongoing public and political debates about the power and regulation of large platform conglomerates, this special issue calls for more critical, conceptual, and empirical studies on platform power. While a lot of valuable rese
Externí odkaz:
https://doaj.org/article/471aa93748dd41b1835c9f875adc0fd0
Publikováno v:
Social Media + Society, Vol 10 (2024)
This article examines how sexual content creators manage their (in)visibility, as they navigate the constraints of online hyper(in)visibility. So far, research has focussed on how creators more generally attempt to enhance their visibility through so
Externí odkaz:
https://doaj.org/article/51d35e719f524b858bd08cc5505aea35
Publikováno v:
In Scandinavian Journal of Management June 2024 40(2)
Autor:
Pierik, A.S., Poell, J.B., Brink, A., Stigter- van Walsum, M., de Roest, R.H., Poli, T., Yaromin, A., Lambin, P., Leemans, C.R., Brakenhoff, R.H.
Publikováno v:
In Radiotherapy and Oncology February 2024 191
Autor:
Bernard A Fox, Rieneke van de Ven, Yoshinobu Koguchi, Venkatesh Rajamanickam, Tara Muijlwijk, Sonja H Ganzevles, Ruud H Brakenhoff, Arjen Brink, Changlin Ke, Joseph N Fass, Jos B Poell, Dennis N L M Nijenhuis, C René Leemans
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background The response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Detailed understanding of the tumor i
Externí odkaz:
https://doaj.org/article/4c0703b158e44abebdb94f559e449d18